Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, researchers observed significant racial disparities in alopecia quality of life research, with fewer studies and less funding focusing on Black patients compared to other racial groups, indicating a need for more inclusive and diverse participant recruitment.

Alopecia areata significantly harms women's self-image, causing reduced confidence and social isolation.

This study found that pulse corticosteroids effectively induce hair regrowth in alopecia areata, with betamethasone showing higher efficacy but more side effects, and treatment success varying depending on age, onset time, and disease type.

In this study, the researchers found that awareness of appearance due to hair loss positively impacted hair loss management behaviors through self-awareness and psychological factors, but appearance management intention did not influence care behaviors.

This study concluded that thiocyanate promotes new cell formation and hair growth in animals and humans, with therapeutic effects seen in 51% of human alopecia areata cases after treatment, attributed to diverse biological mechanisms.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

In this study, 27.9% of Parkinson's disease patients reported hair loss, with a higher incidence linked to a daily levodopa-equivalent dose over 448 mg, suggesting an association between dopaminergic medication use and hair loss complaints.

In this study, the researchers identified traumatic styling practices, such as frequent hair straightening, as a dominant cause of alopecia among women aged 15 to 45 in a dermatology setting, noting that rural women also experienced inflammatory alopecia linked to different etiologies.

In a clinical observation study, researchers documented a case of total alopecia in an 11-year-old child, highlighting a potential link to genetic conditions such as autoimmune polyendocrinopathy candidiasis-ectodermal dystrophy (APECED syndrome) requiring further genetic and serological testing to verify the diagnosis.

This study found that clinical characteristics, concurrent medical conditions, and hair care practices may affect treatment outcomes in patients with central centrifugal cicatricial alopecia.

This case report describes significant improvements in both trichotillomania and bulimia symptoms with N-acetylcysteine treatment, suggesting a potential shared pathophysiological mechanism between the disorders.

In this study, all patients receiving chemotherapy for breast carcinoma experienced chemotoxicities like hair loss, nausea, and fatigue, with no one regimen identified as more toxic than another.

This study found that hair transplant surgery significantly reduced anxiety scores in bald patients over an average period of 12.7 months.

This source reports findings from a case study detailing hair loss in two female patients, published in the JDDG: Journal der Deutschen Dermatologischen Gesellschaft, emphasizing that specific diagnostic outcomes or treatment results are not included in the summary.

This study explored the experiences of adolescents with alopecia and their parents, highlighting the emotional distress caused by the condition and the inadequate response of healthcare professionals to their needs.

This review discusses the evaluation methods for patients with hair loss, emphasizing the importance of history, physical examination, and, when necessary, laboratory tests or biopsy, but it reports no new clinical results.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

In this review, the authors examine the causes, risk factors, and management strategies for chemotherapy-induced hair loss, highlighting its psychological impact and underscoring the role of healthcare providers, especially nurses, in supporting patients through this distressing side effect.

This review discusses telogen effluvium, a common form of hair loss, and reports no new clinical results; the authors outline possible causes, typical prognosis, and management strategies.

This study reviews drug-induced hair changes, noting that hair loss often reverses after stopping the drug, but permanent alopecia cases post-chemotherapy are rising.

This review discusses various treatment options for alopecia areata, focusing on manipulating the immune response around hair follicles, but reports no new clinical results.

This article discusses a severe case of telogen effluvium following brow ptosis repair and stresses the importance of recognizing and addressing stress-induced hair loss, without presenting new clinical findings.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Hair transplantation in East Asians needs special techniques to ensure natural results and prevent complications due to their unique hair and scalp characteristics.

This review discusses the potential pathogenic mechanisms of cicatricial alopecia and emphasizes the need for further research on treatment methods, but it reports no new clinical findings.

This article presents a case history of hair loss in a 16-year-old girl and provides no new research findings.

Mother and son diagnosed with a rare genetic hair loss condition with no effective treatment.

The document reviews key historical figures and discoveries in dermatology.

This case report and literature review discusses Marie-Unna hereditary hypotrichosis and presents no new clinical results.

This chapter reviews the structure, pharmacokinetics, and clinical applications of PEGylated liposomes and reports no new research findings.